Valideus launches in US with Neuman hire

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Valideus launches in US with Neuman hire

New gTLD specialist Valideus, based in London, is launching a sister company, Valideus USA, based in Virginia, USA

Jeff Neuman

Jeff Neuman (right) is joining the new company as senior vice president. For the past five years he has led Neustar’s registry services team, where he worked on the launch of more than 350 new gTLDs such as .nyc.

Valideus managed more than 120 new gTLDs applications for brand owners in the first round of Icann’s new gTLD programme and also provides registry management services.

Neuman, who trained as a lawyer, has been with Neustar for more than 15 years. He was also a member of Icann’s GNSO from 2003 to 2005 and 2010 to 2013 and has chaired a number of Icann groups.

more from across site and SHARED ros bottom lb

More from across our site

New platform, which covers SEPs covering the Wi-Fi 6 and Wi-Fi 7 standards, includes 10 patent owners
The Texas-based IP litigation hires take King & Spalding’s partner appointments from pre-merger Winston & Strawn up to 12 this year
Sunny Su explains how her team overcame challenges with orchard evidence collection to secure a favourable plant variety decision from China’s top court
Flexible working firm continues trajectory from 2025 with appointment of Matthew Grant and Letao Qin
Anousha Davies, associate and trademark attorney at Birketts, unpicks how the university’s reputation enabled it to see off a proposed trademark for ‘Cambridge Rowing’
IP lawyers, who say they are encouraging clients to build up ‘tariff resilience’, should treat the risks posed by recent orders as a core consideration in cross-border licensing
Regulatory changes and damages risks are prompting Canadian firms and clients to opt for settlements in generic and biosimilar cases
News of Via Licensing Alliance adding two new members and Nokia’s proposal to extend interim licences to Warner Bros Discovery and Paramount were also among the top talking points
A new claim filed by Ericsson, and a request for access to documents, were also among recent developments
Cooley and Stikeman Elliott advised 35Pharma on the deal, which will allow GSK to get its hands on S235, an investigational medicine for pulmonary hypertension
Gift this article